English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51879229    線上人數 :  808
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"wu k d"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 431-440 / 1933 (共194頁)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-08-02T02:32:58Z Risk of severe erectile dysfunction in primary hyperaldosteronism: A population-based propensity score matching cohort study Chang C.-H.; SHIH-CHIEH CHUEH; Wu V.-C.; Chen L.; Lin Y.-H.; Hu Y.-H.; Wu K.-D.; Tsai Y.-C.
臺大學術典藏 2021-08-02T02:32:58Z Adrenalectomy Completely Cured Hypertension in Patients with Familial Hyperaldosteronism Type i Who Had Somatic KCNJ5 Mutation Lin Y.-F.; Peng K.-Y.; Chang C.-H.; Hu Y.-H.; Wu V.-C.; SHIH-CHIEH CHUEH; Wu K.-D.
臺大學術典藏 2021-08-02T02:32:57Z Urinary biomarkers predict advanced acute kidney injury after cardiovascular surgery Wang J.-J.; Chi N.-H.; Huang T.-M.; Connolly R.; Chen L.W.; SHIH-CHIEH CHUEH; Kan W.-C.; Lai C.-C.; Wu V.-C.; Fang J.-T.; Chu T.-S.; Wu K.-D.
臺大學術典藏 2021-08-02T02:32:57Z MiRNA-203 modulates aldosterone levels and cell proliferation by targeting wnt5a in aldosterone-producing adenomas Peng K.-Y.; Chang H.-M.; Lin Y.-F.; Chan C.-K.; Chang C.-H.; SHIH-CHIEH CHUEH; Yang S.-Y.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.
臺大學術典藏 2021-08-02T02:32:55Z Case detection and diagnosis of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism Wu V.-C.; Hu Y.-H.; Er L.K.; Yen R.-F.; Chang C.-H.; Chang Y.-L.; Lu C.-C.; Chang C.-C.; Lin J.-H.; Lin Y.-H.; Wang T.-D.; Wang C.-Y.; Tu S.T.; SHIH-CHIEH CHUEH; Tseng F.-Y.; Wu K.-D.; Wang W.-J.; Wu C.-H.; Ho Y.-L.; Lin L.-Y.; Hu Y.-H.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Liao S.-C.; TAIPAI group
臺大學術典藏 2021-08-02T02:32:55Z Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years Wu V.-C.; SHIH-CHIEH CHUEH; Chen L.; Chang C.-H.; Hu Y.-H.; Lin Y.-H.; Wu K.-D.; Yang W.-S.
臺大學術典藏 2021-08-02T02:32:54Z The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes Wu V.-C.; Wang S.-M.; SHIH-CHIEH CHUEH; Yang S.-Y.; Huang K.-H.; Lin Y.-H.; Wang J.-J.; Connolly R.; Hu Y.-H.; Gomez-Sanchez C.E.; Peng K.-Y.; Wu K.-D.
臺大學術典藏 2021-08-02T02:32:54Z Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study Wu V.-C.; Chang C.-H.; Wang C.-Y.; Lin Y.-H.; Kao T.-W.; Lin P.-C.; Chu T.-S.; Chang Y.-S.; Chen L.; Wu K.-D.; SHIH-CHIEH CHUEH
臺大學術典藏 2021-08-02T02:32:53Z Long term outcome of Aldosteronism after target treatments Wu V.-C.; Wang S.-M.; Chang C.-H.; Hu Y.-H.; Lin L.-Y.; Lin Y.-H.; SHIH-CHIEH CHUEH; Chen L.; Wu K.-D.
臺大學術典藏 2021-08-02T02:32:52Z The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old Kuo C.-C.; Balakrishnan P.; Hsein Y.-C.; Wu V.-C.; SHIH-CHIEH CHUEH; Chen Y.-M.; Wu K.-D.; Wang M.-J.; Lin Y.-H.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Huang K.-H.; Chang C.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F.; Lin W.-C.; Hsieh B.-S.; TAIPAI group

顯示項目 431-440 / 1933 (共194頁)
<< < 39 40 41 42 43 44 45 46 47 48 > >>
每頁顯示[10|25|50]項目